Invention Grant
- Patent Title: 5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators
-
Application No.: US16106104Application Date: 2018-08-21
-
Publication No.: US10696662B2Publication Date: 2020-06-30
- Inventor: Guozhang Xu , Gee-Hong Kuo , Micheal Gaul
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D409/10
- IPC: C07D409/10 ; C07D513/04 ; C07D405/14 ; C07D411/14 ; C07D407/14
Abstract:
The present invention is directed to 5-fluoro-C-(aryl or hetercyclyl)-glycoside derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by SGLT activity, more particularly dual SGLT1/2 activity.
Public/Granted literature
- US20190055226A1 5-FLUORO-C-(ARYL OR HETEROCYCLYL)-GLYCOSIDE DERIVATIVES USEFUL AS DUAL SGLT1 / SGLT2 MODULATORS Public/Granted day:2019-02-21
Information query
